
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Capricor Therapeutics, Inc. - CAPR
The investigation concerns whether Capricor and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On May 5, 2025, Capricor issued a press release announcing that after“the completion of a mid-cycle review meeting with the U.S. Food and Drug Administration (FDA) for the Company's Biologics License Application (BLA) seeking full approval for deramiocel, an investigational cell therapy, as a treatment for patients diagnosed with Duchenne muscular dystrophy (DMD) cardiomyopathy”, the FDA had“confirmed its intent to hold an advisory committee meeting” in connection with the BLA.
On this news, Capricor's stock price fell $3.00 per share, or 29.13%, to close at $7.30 per share on May 6, 2025.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See .
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
...
646-581-9980 ext. 7980


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Tommaso Caratelli Introduces Zerix, Focusing On Innovative Risk Strategies
- Stably Introduces Stablecoin Development & Advisory Services For Institutions & Enterprises
- B2PRIME Appoints Former Onezero Sales Head Stuart Brock As Institutional Business Development Manager
- Roam Launches On Binance Alpha And Solana's Meteora DEX, Expands Cross-Chain Access Via BSC Integration
- FBS Releases Market Outlook On Bitcoin Following US-China Trade Truce
- Reddio's Exclusive Token Generation Event (TGE) And Alpha Trading On Binance Wallet - May 29, 2025
Comments
No comment